But Bellito also knew that AstraZeneca used the excuse of cooperating with clinical trials to get related drugs to cooperating laboratories in other countries. This was the company's private behavior, and they really couldn't say anything.

After all, AstraZeneca is a multinational pharmaceutical company, not just a US pharmaceutical company.

Perito's department can only issue warnings and fines to AstraZeneca, but what's the use?

Bellito called the team members angrily, and he wanted to go to AstraZeneca's headquarters in person!

Xia Guo, Changzezhou.

Qu Ping placed a box of osimertinib in front of Chen Xiao.

Chen Xiao has seen this medicine before.

Before rebirth, in the parallel time and space, Chen Jinsong, Chen Xiao's grandfather, suffered from lung cancer, and he took this medicine.

At that time, this drug was not domestically produced, nor did it reach a cooperation agreement with AstraZeneca to introduce it, so Chen Xiao could only buy it from the United States at a high price through personal relationships.

At that time, 1700 yuan per tablet, 1 tablet a day, cost as much as 1,000 yuan a month.

Fortunately, Chen Xiao's financial conditions are good and he can afford it.

Grandpa did prolong his life for a few years through this medicine.

But Chen Ling knew very well that there were tens of thousands of people in Xia Country who couldn't afford this medicine and could only wait to die in bed.

Later, the country introduced the drug to the United States through negotiations, and the price was reduced to 510 yuan a tablet. The cost of taking osimertinib for a month was 10 yuan. After reimbursement by the medical insurance, the monthly cost of the patient was 4590 yuan.

This price is much cheaper than a few years ago, but it is still very expensive for many Xia people.

Especially around 2020, nearly 43% of Xia Guo’s households will have a per capita monthly income of less than 1,090 yuan, 56.5% of the population will have a per capita monthly income of less than 1,500 yuan, and 69% of the population will have a per capita monthly income of less than 2,000 yuan. In other words, the per capita monthly income of most people in the country is less than 2,000 yuan.

This kind of medicine, which is as high as 4,590 yuan per month, is unaffordable even if it is reimbursed by medical insurance.

Therefore, seeing such a medicine, Chen Ling was still filled with emotion.

Chen Xiao said to Qu Ping: "Send the medicine to the medical team, let's see how to treat He Jiang."

Osimertinib has a good effect on brain metastases from lung cancer, so even if He Jiang's lungs have been removed, he still has brain and kidney metastases.

There is absolutely nothing wrong with using this drug.

Chen Xiao added: "Some drugs are sent to the laboratory, and Ah San can prevent them. We optimize the drugs on the basis of imitation, and there should be no problem in circumventing their patented technology."

"By the way, let the Shanghai Stock Exchange and Yanjing know, so they won't be in a hurry."

Chen Xiao also saw the media reports about He Jiang's condition and the inability to get medicines in the past few days.

The reason why the relevant media reported the incident at this point in time was because they did not hold any hope for He Jiang's treatment.

Qu Ping immediately followed what Chen Xiao said.

Yanjing, Xie Fei received a call from Changtian Technology and was told that Osimertinib has been used in He Jiang's clinical treatment.

After receiving this news, Xie Fei was completely shocked!

Xie Fei used all available personal and public relations, but he didn't get the medicine, and the other party's reaction was very tough.

Xie Fei recognized them all!

Who said that the medical technology of their own country is not as good as that of the United States.

If you fall behind, you will be beaten. This has been true since ancient times.

He didn't expect that Changtian Technology could get the medicine so easily.

And it's still in supply.

Xie Fei asked relevant insiders in detail why Changtian Technology obtained Osimertinib.

Xie Fei was even more shocked when he learned that Changtian Technology required many pharmaceutical companies to supply goods immediately at the expense of American business!

You know, Changtian Technology is just a private company.

A private company does not need to require the other party to have a strong sense of national and historical responsibility, after all, the other party wants to make money to eat.

In order to be able to buy medicines, Xie Fei approached many state-owned pharmaceutical companies that have business dealings with AstraZeneca. But the other party was either incapable or afraid of damaging the relationship with AstraZeneca, so they made various excuses to avoid it.

Only Changtian Technology can stand up in the first time, and return its annual business of hundreds of millions of yuan as a bargaining chip to negotiate with the other party.

And Xie Fei is very clear that this matter has nothing to do with Changtian Technology.

He Jiang suffered from small cell lung cancer, not pulmonary fibrosis or other severe lung diseases. Longsky Technology Intensive Care Center is not a professional hospital for cancer treatment.

But Changtian Technology still has the duty to stand up and complete such a difficult task.

Xie Jiang felt very uncomfortable!

Fortunately, Changtian Technology is a technology company of Xia Guo, not a company of America or Toyo.

If Changtian Technology was an overseas company, what a formidable competitor it would be!

Xie Fei immediately sat in front of the computer, wrote the report himself, and reported the situation of Changtian Technology's acquisition of Osimertinib to the higher-ups.

Such companies must be given significant policy and economic support conditions.

Xie Fei even felt that relying on state-owned research institutes to conquer anti-cancer drugs like osimertinib was definitely hopeless, and he could only rely on Changtian Technology.

Xie Fei has stayed in state-owned research institutes before, no matter how much he does or how little he does, his slack is quite serious.

In this case, only fools will have the spirit of scientific research and innovation. It is true that they can do less work and earn more money. Who will really make efforts in scientific research?

Xie Fei understands this situation too well!

On the contrary, Changtian Technology is more dynamic than many state-owned research institutes.

The news that Changtian Technology obtained the drug was quickly known by the media, and many media who had been paying attention to He Jiang's follow-up situation asked Changtian Technology to verify whether they had obtained osimertinib.

In the past few days, a large number of reporters are either crowded in the reporter reception room of the intensive care center, or frantically calling Changtian Technology for verification.

Seeing the enthusiasm of the reporters, in order to ensure the normal working order of the treatment center, Qu Ping only held a brief press conference after seeking Chen Xiao's opinion.

"Hi Director Qu, may I ask if Changtian Technology has managed to get Osimertinib?"

"Director Qu, reporter from National Radio and Television Station, Xu Tao. May I ask how Changtian Technology got Osimertinib, and has the drug been used in Mr. He's treatment?"

"Director Qu, I'm a reporter from Xinlang.com. As far as we know, AstraZeneca has banned the sale or gift of osimertinib to any country, individual or organization in the world. How did Changtian Technology obtain it? What is the current treatment effect of this drug?"

In fact, this time Qu Ping organized this press conference, feeling very upset.

What time is it?

The medical team of the intensive care center was rushing to save the patient's life, while the reporters on this side were concerned about how the medicine came from.

Qu Ping did not have a good face, and said: "Reporters have asked a lot of questions, so I will not answer them one by one. The medicine was brought back by Changtian Technology through certain efforts, and the treatment is currently in progress. I hope all reporters can give the treatment team For a certain period of time, Mr. He will also be given a quiet treatment environment."

After Qu Ping gave a simple answer, the reporters at the scene cheered and applauded, discussing excitedly.

"Changtian Technology has a solution!"

"That's right, many departments have tried various methods, but they can't get Yaochangtian Technology to get it done as soon as it comes out."

"It will be easy when the medicine is back! The effect should be very powerful. I have read some experimental data from AstraZeneca, and osimertinib has a very good effect on lung cancer metastases."

Qu Ping was quite surprised.

The reporters were actually applauding.

Both Chen Xiao and Qu Ping felt that it was shameful for the Xia people to try their best to go overseas to seek medicine. What the **** are these people applauding?

Celebrate the other party giving you a little anti-cancer drug?

Qu Ping pressed her hand, and said with a bad face: "I don't think it's something to be proud of that so many scientific research institutions and pharmaceutical companies in my country can't produce corresponding anticancer drugs. Today's press conference is coming soon." Here, thank you all."

After Qu Ping dropped these words, she left the conference room, leaving the reporters looking at each other in blank dismay.

The reporters also blushed a little, and suddenly felt that what Qu Ping said made sense.

What are you all excited about?

I am very happy because of a little charity from Western companies

The medicine was not produced by Xia, nor was it bought through normal trade. What is there to be happy about?

Seeing the back view of Qu Ping leaving, the reporters suddenly had a deep understanding of Changtian Technology.

They felt that this private company was different from the companies they had known in the past.

In the past, especially in certain hospitals or scientific research centers, if He Jiang’s incident also happened, they would have tried everything possible to buy Osimertinib from AstraZeneca.

It must be rushing to hold a press conference, rushing to ask for credit, thinking that it is a great merit to be able to buy the drug from AstraZeneca, and it must be reported in a big way, and even wear a medal of merit and a red flower.

However, Changtian Technology's approach is completely different from theirs.

This time, Changtian Technology almost single-handedly overwhelmed its own medical industry in Mizhou, which was able to make the pharmaceutical giants in the U.S. compromise and obtain related medicines.

But Changtian Technology has never thought this is a merit, but a particularly shameful thing.

Because Xia Guo's technology companies are not strong, they cannot rely on their own capabilities to produce anticancer drugs comparable to osimertinib.

Because the country of Xia is not strong enough, we have many research institutes, and the research funds are quite generous, but we don't even have a pharmaceutical company that can replace AstraZeneca.

The idea shames many journalists.

"Changtian Technology hopes that anti-cancer drugs will no longer be purchased abroad!" Half an hour later, Xinlang used this as the headline and reported the entire content of the interview with Changtian Technology's press conference on the front page.

The content of the report basically restored the whole process of the press conference. At the end of the report, the commentator of Xinlang sighed and said:

"Changtian Technology is not excited because it has overcome all difficulties and purchased Osimertinib, but is frustrated because no domestic pharmaceutical company can produce an anticancer drug similar to Osimertinib!

We hope that more Xiaguo scientific research companies will stand up, and hope that next time we need comparable drugs, a certain technology company in Xiaguo can provide domestically produced drugs as quickly as possible, instead of trying everything possible to find them. So from abroad. "

Not only Xinlang, but many media reporters who participated in the long-day technology conference had different feelings.

Xinlang who followed one after another reported the relevant situation.

Netizens were very surprised when they saw this press conference of Changtian Technology.

Because Changtian Technology was able to obtain Osimertinib through its own means, which is already a very remarkable thing.

But Changtian Technology did not take the credit as everyone imagined, but felt guilty for not being able to develop similar drugs.

This pursuit of excellence in science and technology is exactly what Xia Guo's scientific research institutions lack.

Fei also saw the relevant media reports, and he took a sip of tea silently.

This is the scientific research company Xia Guo needs.

He Jiang's condition stabilized after treatment.

But no one can guarantee that the tumor will not spread or metastasize.

We can only expect that after the condition stabilizes, the lesions will gradually shrink and finally disappear.

After He Jiang completed the combined colony transplantation and lung resection, he was able to sit on the bed and whisper something.

This time Chen Xiao and Qu Ping went to visit him, and it happened that the leaders and colleagues of Institute 606 were also there.

He Jiang's students and subordinates held notebooks and listened to He Jiang's every sentence ~lightnovelpub.net~ He Jiang said: "Although our engine can be installed on the plane, there are still some defects."

"One is that the temperature before the vortex reaches 1500K, and the efficiency will be reduced by 10%. In addition, if the thrust is increased, the fuel efficiency will be reduced to 60%, which will not reach our combat radius of 1200-1500km. Our design thrust is 17 tons. The actual thrust is less than 12 tons."

"I...my latest data shows..." He Jiang panted heavily.

"Teacher, don't worry, speak slowly."

The students hurriedly handed the water to He Jiang.

After He Jiang had his lungs removed, he relied on the diaphragm of his chest to make his voice, so his voice sounded weird and difficult.

He Jiang took a sip of water, and then he recovered after a while, and said, "Currently, the turbofan 10 overhaul time is less than 1,000 hours, and the efficiency is too low..."

"Because of technical reasons, we have not yet been able to match the thrust loss-of-quantity nozzle..."

The students stopped He Jiang's words, very disappointed.

They all thought that the turbofan 10 was successful after decades of research, but they didn't expect that there were so many details. The students knew these things before, but being reminded repeatedly by He Jiang on this occasion, everyone felt uncomfortable.

At this time, Chen Xiao said: "The turbofan-10 uses three-stage fans, nine-stage rectification, one stage of high pressure, and one stage of low pressure, which is the so-called 3+9+1+1 structure with high thrust, high thrust-to-weight ratio and low bypass ratio. engine."

"However, with the current thrust, if it is equipped with a loss of volume nozzle, instead of being able to increase the speed in an emergency, it will easily cause a stall. The reason is that the thrust is still insufficient."

When Chen Xiao said this, everyone turned their heads.